Literature DB >> 28849195

Genome-wide DNA methylation analysis in permanent atrial fibrillation.

Guochang Zhao1, Jian Zhou1, Jie Gao1, Yan Liu1, Song Gu1, Xitao Zhang1, Pixiong Su1.   

Abstract

Atrial fibrillation (AF) is a highly heterogeneous genetic disease; however, the pathogenesis of AF cannot be explained by genetic variants alone. DNA methylation is a heritable method of gene expression regulation, and may be a potential regulatory mechanism in AF. Therefore, in the present study, the genome‑wide DNA methylation pattern in cells derived from the left atrium of patients with permanent AF (n=7) was compared with that of healthy heart donors (n=4) with a normal sinus rhythm (SR). Enriched biological functions of the differentially methylated genes were assessed. Integrated analysis of genome‑wide methylation and mRNA expression profiles was performed, and reverse transcription quantitative‑polymerase chain reaction (RT‑qPCR) was used to determine the expression levels of four selected genes. A total of 417 differentially methylated CpG sites were identified in the fibrillating atrium (P<0.05; |β|>0.17); the majority of which were located in gene‑body and intergenic regions outside of CpG islands. Aberrantly methylated genes participated in the activation of inflammation, sodium and potassium ion transport, fibrosis and the reduction of lipid metabolism. Hypermethylation in the AF susceptible loci, paired‑like homeodomain transcription factor 2 (chromosome 4q25) and coiled‑coil domain containing 141 (chromosome 2q31), as well as hypomethylation in the calcium voltage‑gated channel subunit α1C (chromosome 12p13) locus, were identified in all patients with AF. Of the 420 upregulated and 567 downregulated genes previously identified in patients with AF relative to those with normal SR (fold‑change >2.0; P≤0.05), 12 genes were hypomethylated and eight genes were hypermethylated in each group, respectively (|β|>0.2: P<0.05). RT‑qPCR analysis of four of these genes supported the modulatory effect of DNA methylation on gene expression. These results suggest that DNA methylation‑mediated regulation of gene expression may serve an important role in AF pathogenesis, and several susceptible AF CpG loci were identified which may be involved in the initiation of AF.

Entities:  

Mesh:

Year:  2017        PMID: 28849195     DOI: 10.3892/mmr.2017.7221

Source DB:  PubMed          Journal:  Mol Med Rep        ISSN: 1791-2997            Impact factor:   2.952


  10 in total

Review 1.  Genetics of Atrial Fibrillation in 2020: GWAS, Genome Sequencing, Polygenic Risk, and Beyond.

Authors:  Carolina Roselli; Michiel Rienstra; Patrick T Ellinor
Journal:  Circ Res       Date:  2020-06-18       Impact factor: 17.367

2.  Clinical epigenomics for cardiovascular disease: Diagnostics and therapies.

Authors:  Matthew A Fischer; Thomas M Vondriska
Journal:  J Mol Cell Cardiol       Date:  2021-02-06       Impact factor: 5.000

Review 3.  Animal Models to Study Cardiac Arrhythmias.

Authors:  Daniel J Blackwell; Jeffrey Schmeckpeper; Bjorn C Knollmann
Journal:  Circ Res       Date:  2022-06-09       Impact factor: 23.213

4.  DNA Methylation-Based Prediction of Post-operative Atrial Fibrillation.

Authors:  Matthew A Fischer; Aman Mahajan; Maximilian Cabaj; Todd H Kimball; Marco Morselli; Elizabeth Soehalim; Douglas J Chapski; Dennis Montoya; Colin P Farrell; Jennifer Scovotti; Claudia T Bueno; Naomi A Mimila; Richard J Shemin; David Elashoff; Matteo Pellegrini; Emma Monte; Thomas M Vondriska
Journal:  Front Cardiovasc Med       Date:  2022-05-10

Review 5.  Epigenetics in atrial fibrillation: A reappraisal.

Authors:  Rosa Doñate Puertas; Rishi Arora; Sophie Rome; Babken Asatryan; H Llewelyn Roderick; Philippe Chevalier
Journal:  Heart Rhythm       Date:  2021-01-10       Impact factor: 6.779

6.  Plasma Concentrations and Dietary Intakes of Choline and Betaine in Association With Atrial Fibrillation Risk: Results From 3 Prospective Cohorts With Different Health Profiles.

Authors:  Hui Zuo; Gard F T Svingen; Grethe S Tell; Per M Ueland; Stein E Vollset; Eva R Pedersen; Arve Ulvik; Klaus Meyer; Jan E Nordrehaug; Dennis W T Nilsen; Kaare H Bønaa; Ottar Nygård
Journal:  J Am Heart Assoc       Date:  2018-04-12       Impact factor: 5.501

Review 7.  Epigenetic Mechanism and Therapeutic Implications of Atrial Fibrillation.

Authors:  Dan Li; Jiali Nie; Yu Han; Li Ni
Journal:  Front Cardiovasc Med       Date:  2022-01-21

Review 8.  Epigenetic and Transcriptional Networks Underlying Atrial Fibrillation.

Authors:  Antoinette F van Ouwerkerk; Amelia W Hall; Zachary A Kadow; Sonja Lazarevic; Jasmeet S Reyat; Nathan R Tucker; Rangarajan D Nadadur; Fernanda M Bosada; Valerio Bianchi; Patrick T Ellinor; Larissa Fabritz; James F Martin; Wouter de Laat; Paulus Kirchhof; Ivan P Moskowitz; Vincent M Christoffels
Journal:  Circ Res       Date:  2020-06-18       Impact factor: 17.367

9.  Plasma Choline as a Diagnostic Biomarker in Slow Coronary Flow.

Authors:  Yuan-Ting Zhu; Ling-Ping Zhu; Zhen-Yu Wang; Xue-Ting Qiu; Wan-Zhou Wu; Wei-Wang Liu; Yu-Yu Feng; Wen-Kai Xiao; Xin Luo; Zhen-Yu Li; Chuan-Chang Li
Journal:  Cardiol Res Pract       Date:  2020-01-25       Impact factor: 1.866

10.  The Joint Analysis of Multi-Omics Data Revealed the Methylation-Expression Regulations in Atrial Fibrillation.

Authors:  Ban Liu; Xin Shi; Keke Ding; Mengwei Lv; Yongjun Qian; Shijie Zhu; Changfa Guo; Yangyang Zhang
Journal:  Front Bioeng Biotechnol       Date:  2020-03-12
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.